Screener
Maze Therapeutics MAZE Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 500,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 55,504,574 and 49,335,551 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; 10,372 shares subject to repurchase as of June 30, 2026 and December 31, 2025 | 56 | 49 |
| Additional paid-in-capital | 1,011,985 | 844,354 |
| Accumulated other comprehensive (loss) income | (435) | 110 |
| Accumulated deficit | (558,482) | (489,547) |
| Total stockholders’ equity | 453,124 | 354,966 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Maze Therapeutics's common stock?
- Maze Therapeutics (MAZE) reported common stock of $56K in Q2 2026.
- How has Maze Therapeutics's common stock changed year-over-year?
- Maze Therapeutics's common stock increased by 27.3% year-over-year, from $44K to $56K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Maze Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude